p16INK4 mutations and altered expression in human tumors and cell lines.
Okamoto
A
A
Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Demetrick
D J
DJ
Spillare
E A
EA
Hagiwara
K
K
Hussain
S P
SP
Bennett
W P
WP
Forrester
K
K
Gerwin
B
B
Greenblatt
M S
MS
Serrano
M
M
D001483:Base Sequence; D002352:Carrier Proteins / Q000235:genetics*; D002460:Cell Line; D019938:Cyclin D1; D019941:Cyclin-Dependent Kinase Inhibitor p16; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors; D016213:Cyclins / Q000235:genetics; D017931:DNA Primers / Q000235:genetics; D004791:Enzyme Inhibitors / Q000378:metabolism; D005260:Female; D017353:Gene Deletion; D015972:Gene Expression Regulation, Neoplastic; D016161:Genes, Retinoblastoma; D016147:Genes, Tumor Suppressor; D006720:Homozygote; D006801:Humans; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000201:enzymology / Q000235:genetics*; D015513:Oncogene Proteins / Q000235:genetics
D002352:Carrier Proteins; D019941:Cyclin-Dependent Kinase Inhibitor p16; D016213:Cyclins; D017931:DNA Primers; D004791:Enzyme Inhibitors; D015513:Oncogene Proteins; D019938:Cyclin D1; D018844:Cyclin-Dependent Kinases